Particle.news
Download on the App Store

MHRA Recalls Batch of Ramipril 2.5mg After Packaging Error

A manufacturing mistake that could place 10mg blister strips inside 2.5mg cartons threatens patient safety, prompting an MHRA-ordered pharmacy withdrawal.

Overview

  • A healthcare professional found two blister strips labelled Ramipril 10mg inside a sealed carton marked 2.5mg, and the MHRA announced a precautionary recall of the affected batch on Thursday.
  • The recalled product is Crescent Pharma Limited Ramipril 2.5mg, batch GR155023, pack size 28, first distributed 16 January 2026 with expiry 08/2027.
  • The MHRA says the error appears to have happened during packaging at the manufacturing site and has instructed pharmacies and healthcare professionals to stop supplying and return all remaining stock from the named batch.
  • Patients should check the outer carton for batch GR155023 and must not take the medicine if the blister strips inside are labelled 10mg; anyone who thinks they have taken the higher dose should contact their dispensing pharmacy and seek medical advice.
  • Ramipril is a widely used ACE inhibitor for high blood pressure, heart failure and some kidney conditions, and taking a higher dose can cause lightheadedness, fainting, fatigue or altered kidney function so suspected side effects should be reported via the MHRA Yellow Card scheme.